Pulse Biosciences Inc

Last updated September 27, 2026

Organization details

Legal name
Pulse Biosciences Inc
Former names
Electroblate, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Hayward
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
PLSE
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001625101
EIN
46-5696597

Board of directors

Chief executives

Paul A. Laviolette · Chief Executive Officer
Dates unknown
Burke Thomas Barrett · President and CEO
Since May 2024

Director election results

Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

6 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Network of Pulse Biosciences Inc's board connections Summit Therapeutics Inc. Summit Therapeutics In... Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals... Edwards Lifesciences Corporation Edwards Lifesciences C... Hyperfine Inc. Hyperfine Inc. Den Broek Richard Van Den Broek Richard Va... Mahkam Zanganeh Mahkam Zanganeh Manmeet Singh Soni Manmeet Singh Soni Maria Sainz Maria Sainz Paul A. Laviolette Paul A. Laviolette Robert W. Duggan Robert W. Duggan Pulse Biosciences Inc
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$13,495,279
6 purchases by 3 insiders
Sold, last 12 months
$2,932,200
7 sales by 1 insider
Date Insider Transaction Shares Price Value
Sep 1, 2026 Teplitsky Liane Rae Officer (Chief Operating Officer) Open-market purchase +1,001 $49.95 $50,000
Aug 31, 2026 Teplitsky Liane Rae Officer (Chief Operating Officer) Open-market purchase +1,024 $48.80 $49,971
Aug 28, 2026 Teplitsky Liane Rae Officer (Chief Operating Officer) Open-market purchase +1,034 $48.35 $49,994
Aug 26, 2026 Teplitsky Liane Rae Officer (Chief Operating Officer) Open-market purchase +1,036 $48.24 $49,977
May 11, 2026 Paul A. Laviolette Director, Officer (Chief Executive Officer) Open-market purchase +15,000 $19.69 $295,350
May 11, 2026 Robert W. Duggan Director, 10% owner Open-market purchase +660,233 $19.69 $12,999,988
Feb 18, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Option exercise +5,000 $1.53 $7,650
Feb 18, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Open-market sale −5,000 $23.64 $118,200
Feb 17, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Option exercise +20,000 $1.53 $30,600
Feb 17, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Open-market sale −20,000 $23.63 $472,600
Feb 13, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Option exercise +20,000 $1.53 $30,600
Feb 13, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Open-market sale −20,000 $23.53 $470,600
Feb 12, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Option exercise +20,000 $1.53 $30,600
Feb 12, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Open-market sale −20,000 $23.37 $467,400
Feb 11, 2026 Danahy Kevin Patrick Officer (Chief Commercial Officer) Option exercise +20,000 $1.53 $30,600

Organizations in the same sector, closest in location and size first.

Questions about Pulse Biosciences Inc

Who is the CEO of Pulse Biosciences Inc?

Burke Thomas Barrett has been Pulse Biosciences Inc's President and CEO since May 2024.

How many directors are on Pulse Biosciences Inc's board?

Pulse Biosciences Inc's board has 10 directors: Burke Thomas Barrett, Darrin Uecker, Den Broek Richard Van, Mahkam Zanganeh, Manmeet Singh Soni, Maria Sainz, Mitchell E. Levinson, Paul A. Laviolette, Robert W. Duggan and Shelley D. Spray.

Are Pulse Biosciences Inc insiders buying or selling shares?

Over the last 12 months, Pulse Biosciences Inc insiders bought $13.5 million of shares in 6 purchases and sold $2.9 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="pulse-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.